Portal de investigación
Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome.
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Cillóniz C
- Dambrava P
- Gabarrús A
- Ferrer M
- Prina E
- Niederman MS
Grupos
Abstract
Although the benefits of systemic corticosteroids in community-acquired pneumonia (CAP) are not clear, their use is frequent in clinical practice. We described the frequency of this practice, patients' characteristics and its clinical impact.
Datos de la publicación
- ISSN/ISSNe:
- 1323-7799, 1440-1843
- Tipo:
- Article
- Páginas:
- 263-271
- DOI:
- 10.1111/resp.12013
- PubMed:
- 23134361
- Factor de Impacto:
- 1,411 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
RESPIROLOGY WILEY
Citas Recibidas en Web of Science: 24
Documentos
- No hay documentos
Filiaciones
Keywords
- adjunctive therapy; clinical stability; community-acquired pneumonia; mortality; systemic corticosteroid
Campos de Estudio
Cita
POLVERINO E,Cillóniz C,Dambrava P,Gabarrús A,Ferrer M,AGUSTÍ C,Prina E,MONTULL B,MENENDEZ R,Niederman MS,TORRES A. Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome. Respirology. 2013. 18. (2):p. 263-271. IF:3,495. (2).